Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
Marathon Digital Holdings
MARA
$3.55B
| $10M | ﹤0.01% |
1,877,600
-110,500
| -6% | -$1.48M |
|
2602
Blackstone Mortgage Trust
BXMT
$2.44B
| $10M | ﹤0.01% |
362,179
-634,215
| -64% | -$19.2M |
|
2603
CALL
Johnson Controls International
JCI
$93.1B
| $10M | ﹤0.01% |
208,900
-208,200
| -50% | -$11.6M |
|
2604
Vanguard S&P 500 ETF
VOO
$1.04T
| $10M | ﹤0.01% |
28,817
-30
| -0.1% | -$11.3K |
|
2605
CALL
Dillards
DDS
$8.76B
| $9.99M | ﹤0.01% |
45,300
-6,000
| -12% | -$1.73M |
|
2606
Fortuna Silver Mines
FSM
$3.16B
| $9.98M | ﹤0.01% |
3,514,263
+2,651,591
| +307% | +$9.23M |
|
|
MPT
2607
CALL
Medical Properties Trust
MPT
$2.5B
| $9.98M | ﹤0.01% |
653,300
+363,300
| +125% | +$6.54M |
|
2608
CALL
Bath & Body Works
BBWI
$3.91B
| $9.97M | ﹤0.01% |
370,300
-369,800
| -50% | -$16.1M |
|
2609
IDEAYA Biosciences
IDYA
$3.49B
| $9.95M | ﹤0.01% |
721,044
+360,452
| +100% | +$4.01M |
|
2610
Newmont
NEM
$124B
| $9.93M | ﹤0.01% |
166,422
-644,577
| -79% | -$45.6M |
|
2611
AN2 Therapeutics
ANTX
$226M
| $9.92M | ﹤0.01% |
1,333,816
-86,035
| -6% | -$1.14M |
|
2612
Royal Bank of Canada
RY
$301B
| $9.92M | ﹤0.01% |
102,477
-119,268
| -54% | -$12.2M |
|
2613
PUT
Teradata
TDC
$2.57B
| $9.92M | ﹤0.01% |
268,000
-79,200
| -23% | -$3.16M |
|
2614
PUT
Doximity
DOCS
$4.42B
| $9.91M | ﹤0.01% |
284,700
+56,200
| +25% | +$2.21M |
|
2615
Omnicom Group
OMC
$24B
| $9.9M | ﹤0.01% |
155,696
-68,284
| -30% | -$5.05M |
|
2616
CALL
ProShares UltraPro Dow 30
UDOW
$924M
| $9.9M | ﹤0.01% |
404,800
+53,200
| +15% | +$1.6M |
|
|
AYX
2617
PUT
DELISTED
Alteryx Inc
AYX
| $9.89M | ﹤0.01% |
204,300
-38,000
| -16% | -$2.27M |
|
2618
CALL
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $9.89M | ﹤0.01% |
143,400
+114,500
| +396% | +$8.27M |
|
2619
CALL
Appian
APPN
$2.54B
| $9.89M | ﹤0.01% |
208,800
+11,400
| +6% | +$573K |
|
2620
PUT
Cenovus Energy
CVE
$57.2B
| $9.89M | ﹤0.01% |
520,100
-25,600
| -5% | -$509K |
|
2621
United Natural Foods
UNFI
$2.93B
| $9.89M | ﹤0.01% |
250,918
+3,364
| +1% | +$141K |
|
2622
CALL
H&R Block
HRB
$6.83B
| $9.88M | ﹤0.01% |
279,700
+68,000
| +32% | +$2.1M |
|
|
PRMW
2623
DELISTED
Primo Water Corporation
PRMW
| $9.86M | ﹤0.01% |
737,073
+374,563
| +103% | +$5.27M |
|
2624
CALL
Louisiana-Pacific
LPX
$5.17B
| $9.86M | ﹤0.01% |
188,100
+50,000
| +36% | +$3.21M |
|
2625
PUT
Bumble
BMBL
$358M
| $9.85M | ﹤0.01% |
349,800
+105,200
| +43% | +$2.86M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.